These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8847528)

  • 21. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus.
    Bruña-Romero O; Lasarte JJ; Wilkinson G; Grace K; Clarke B; Borrás-Cuesta F; Prieto J
    Hepatology; 1997 Feb; 25(2):470-7. PubMed ID: 9021966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HCV-specific cytotoxic T lymphocyte and its epitope].
    Morita H; Imawari M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):155-8. PubMed ID: 15359784
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein.
    Bertoletti A; Chisari FV; Penna A; Guilhot S; Galati L; Missale G; Fowler P; Schlicht HJ; Vitiello A; Chesnut RC
    J Virol; 1993 Apr; 67(4):2376-80. PubMed ID: 7680391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
    J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.
    Voeten JT; Bestebroer TM; Nieuwkoop NJ; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2000 Aug; 74(15):6800-7. PubMed ID: 10888619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
    Liu Q; Zheng Y; Yu Y; Tan Q; Huang X
    Int Immunopharmacol; 2012 Jun; 13(2):141-7. PubMed ID: 22480777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
    Sutton J; Rowland-Jones S; Rosenberg W; Nixon D; Gotch F; Gao XM; Murray N; Spoonas A; Driscoll P; Smith M
    Eur J Immunol; 1993 Feb; 23(2):447-53. PubMed ID: 7679646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patr-A and B, the orthologues of HLA-A and B, present hepatitis C virus epitopes to CD8+ cytotoxic T cells from two chronically infected chimpanzees.
    Kowalski H; Erickson AL; Cooper S; Domena JD; Parham P; Walker CM
    J Exp Med; 1996 Apr; 183(4):1761-75. PubMed ID: 8666933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extensive alanine substitutions increase binding affinity of an influenza nucleoprotein peptide to HLA-Aw68 and do not abrogate peptide-specific CTL recognition.
    Collins EJ; Booth BL; Cerundolo V
    J Immunol; 1999 Jan; 162(1):331-7. PubMed ID: 9886403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional compensation of a detrimental amino acid substitution in a cytotoxic-T-lymphocyte epitope of influenza a viruses by comutations.
    Rimmelzwaan GF; Berkhoff EG; Nieuwkoop NJ; Fouchier RA; Osterhaus AD
    J Virol; 2004 Aug; 78(16):8946-9. PubMed ID: 15280506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
    Leroux-Roels G; Esquivel CA; DeLeys R; Stuyver L; Elewaut A; Philippé J; Desombere I; Paradijs J; Maertens G
    Hepatology; 1996 Jan; 23(1):8-16. PubMed ID: 8550052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition.
    Kammer AR; van der Burg SH; Grabscheid B; Hunziker IP; Kwappenberg KM; Reichen J; Melief CJ; Cerny A
    J Exp Med; 1999 Jul; 190(2):169-76. PubMed ID: 10432280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.
    Berkhoff EG; de Wit E; Geelhoed-Mieras MM; Boon AC; Symons J; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2005 Sep; 79(17):11239-46. PubMed ID: 16103176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
    Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
    Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.
    Falk K; Rötzschke O; Deres K; Metzger J; Jung G; Rammensee HG
    J Exp Med; 1991 Aug; 174(2):425-34. PubMed ID: 1713253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
    Rimmelzwaan GF; Boon AC; Voeten JT; Berkhoff EG; Fouchier RA; Osterhaus AD
    Virus Res; 2004 Jul; 103(1-2):97-100. PubMed ID: 15163496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response.
    Wang JH; Layden TJ; Eckels DD
    Hum Immunol; 2003 Jul; 64(7):662-73. PubMed ID: 12826368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Priming of cytotoxic T lymphocytes at various stages of ontogeny with transfectoma cells expressing a chimeric Ig heavy chain gene bearing an influenza virus nucleoprotein peptide.
    Kuzu Y; Kuzu H; Zaghouani H; Bona C
    Int Immunol; 1993 Oct; 5(10):1301-7. PubMed ID: 8268136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.